DrugPatentWatch Database Preview

Pfizer Company Profile

Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for PFIZER, and when can generic versions of PFIZER drugs launch?

PFIZER has one hundred and ninety-two approved drugs.

There are thirty-two US patents protecting PFIZER drugs. There is one tentative approval on PFIZER drugs.

There are seven hundred patent family members on PFIZER drugs in sixty-six countries and two hundred and five supplementary protection certificates in nineteen countries.

Summary for Pfizer

International Patents:	700
US Patents:	32
Tradenames:	156
Ingredients:	126
NDAs:	192
Drug Master File Entries:	3
Patent Litigation for Pfizer:	See patent lawsuits for Pfizer
PTAB Cases with Pfizer as petitioner:	See PTAB cases with Pfizer as petitioner

Drugs and US Patents for Pfizer

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Pfizer	FRAGMIN	dalteparin sodium	INJECTABLE;SUBCUTANEOUS	020287-005	Apr 4, 2002		RX	Yes	No
Pfizer	PENICILLIN G PROCAINE	penicillin g procaine	INJECTABLE;INJECTION	060099-001	Approved Prior to Jan 1, 1982		DISCN	No	No
Pfizer	GLUCOTROL XL	glipizide	TABLET, EXTENDED RELEASE;ORAL	020329-001	Apr 26, 1994	AB	RX	Yes	No
Pfizer	TERRAMYCIN	oxytetracycline hydrochloride	CAPSULE;ORAL	050286-001	Approved Prior to Jan 1, 1982		DISCN	No	No
Pfizer	ZYVOX	linezolid	TABLET;ORAL	021130-001	Apr 18, 2000		DISCN	Yes	No	6,514,529*PED				Y
Pfizer	DIABINESE	chlorpropamide	TABLET;ORAL	011641-006	Approved Prior to Jan 1, 1982		DISCN	Yes	No

Expired US Patents for Pfizer

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Pfizer	XELJANZ	tofacitinib citrate	SOLUTION;ORAL	213082-001	Sep 25, 2020	6,956,041
Pfizer	FELDENE	piroxicam	CAPSULE;ORAL	018147-002	Apr 6, 1982	3,674,876
Pfizer Inc	GEODON	ziprasidone hydrochloride	SUSPENSION;ORAL	021483-001	Mar 29, 2006	6,245,766
Pfizer	LONITEN	minoxidil	TABLET;ORAL	018154-003	Approved Prior to Jan 1, 1982	3,461,461
Pfizer	DIFLUCAN	fluconazole	TABLET;ORAL	019949-003	Jan 29, 1990	4,416,682
Pfizer	MINIPRESS	prazosin hydrochloride	CAPSULE;ORAL	017442-002	Approved Prior to Jan 1, 1982	3,663,706

Paragraph IV (Patent) Challenges for PFIZER drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
	Oral Suspension	100 mg/5 mL		2009-08-03
	Injection	2 mg/mL, 100 mL bag		2009-12-29
	Tablets	5 mg		2016-11-07
	Delayed-release Tablets	50 mg/0.2 mg		2009-06-29
	Extended-release Tablets	82.5 mg and 165 mg		2018-02-02
	Capsules	75 mg, 100 mg and 125 mg		2019-02-04
	Extended-release Tablets	82.5 mg and 165 mg		2018-02-02
	Oral Solution	20 mg/mL		2010-05-19
	Extended-release Tablets	11 mg		2016-11-07
	Capsules	0.125 mg, 0.25 mg, and 0.5 mg		2014-05-01
	Capsules	20 mg, 40 mg, 60 mg and 80 mg		2005-02-07
	Tablets	600 mg		2005-12-21
	Injection	2 mg/mL, 300 mL bag		2009-09-01
	Tablets	1 g		2005-08-23
	Delayed-release Tablets	75 mg/0.2 mg		2008-11-28
	Extended-release Tablets	330 mg		2018-01-29
	Extended-release Tablets	330 mg		2018-01-29
	Capsules	25 mg, 50 mg, 75 mg, 100 mg, 150 mg, 200 mg, 225 mg and 300 mg		2008-12-30
	Extended-release Tablets	4 mg and 8 mg		2012-10-31
	Capsules	5 mg and 10 mg		2005-06-21
	Injection	20 mg/mL, 2 mL and 5 mL vials		2004-07-26
	For Injection	500 mg/vial		2011-06-17

International Patents for Pfizer Drugs

Country	Patent Number	Estimated Expiration
Canada	2395603
Portugal	1551372
Croatia	P20170287
Israel	178822
Canada	2400118
Israel	190827

Supplementary Protection Certificates for Pfizer Drugs

Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
0584952	99C0004	Belgium		PRODUCT NAME: ESTRADIOL, HEMIHYDRATE, NORETHISTERONE, ACETATE; NAT. REGISTRATION NO/DATE: NL 23753 19981210; FIRST REGISTRATION: SE - 14 007 19980306
1666481	37/2017	Austria		PRODUCT NAME: TOFACITINIB, GEGEBENENFALLS IN FORM EINES PHARMAZEUTISCH VERTRAEGLICHEN SALZES, EINSCHLIESSLICH DES CITRATS; REGISTRATION NO/DATE: EU/1/17/1178 (MITTEILUNG) 20170324
1746999	PA2019016,C1746999	Lithuania		PRODUCT NAME: DAKOMITINIBO MONOHIDRATAS; REGISTRATION NO/DATE: EU/1/19/1354 20190402
1746976	17C1027	France		PRODUCT NAME: SEL DE SUCROSOFATE D'IRINOTECAN; REGISTRATION NO/DATE: EU/1/16/1130 20161018
2170860	122020000057	Germany		PRODUCT NAME: GLASDEGIB, GEGEBENENFALLS IN FORM EINES PHARMAZEUTISCH ANNEHMBAREN SALZES DAVON, EINSCHLIESSLICH DES MALEATSALZES.; REGISTRATION NO/DATE: EU/1/20/1451 20200626
2170860	PA2020528	Lithuania		PRODUCT NAME: GLASDEGIBAS, PASIRINKTINAI FARMACINIU POZIURIU PRIIMTINOS DRUSKOS, ISKAITANT MALEATO DRUSKA, PAVIDALU; REGISTRATION NO/DATE: EU/1/20/1451 20200626

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Pfizer
• Pfizer Global
• Pfizer Inc
• Pfizer Labs
• Pfizer Pharms